PPT-Ebola phase 1 vaccine trial

A case study of best practices in community engagement Ms Maureen Njue Dr Patricia Njuguna KEMRI Wellcome Trust Research Programme Kenya Outline KEMRIWellcome Trust Kilifi . 573845744257452574555745557444573885737657462574555745357449574605738857376574565744557445573885737657456574555745557456573885737657459574635744557441574605738857376 VHPHQ5735957347VSLW5735957347RWKHU5734757536XLGV57356 Objects contaminated with the Science . and . Politics. : . The . Case of The Ebola Clinical Trials . in . Ghana. Ama. . Edwin.  . MB.  ChB; MPhil (Psych); . D.Bioethics. Overview. . Ghana’s Role in the Ebola . Vaccine Clinical . Pandemics and Emerging Infections. Sarah Gilbert, Jenner Institute, University of Oxford. THE JENNER INSTITUTE. a partnership between Oxford University and . the . Pirbright. Institute . - Developing innovative vaccines. Virus . Disease: treatment, gaps and options. Ellis Owusu-Dabo . (BSc, MB ChB. , MSc, PhD, MWACP, FGCP) . Director, . KCCR/KNUST, Kumasi. , . Ghana . www.kccr-ghana.org. . Established in . October 1997. Where did they get it?. How do you get the virus? . The EBOLA Health Commissioner. The EBOLA Health Commissioner . Understand science of disease and its transmission. Interrupt the transmission of the virus. AAMC Briefing. Dr. Jim LeDuc. Director. Galveston National Laboratory. University of Texas Medical Branch. 13 October 2015. GNL Mission. The mission of the GNL is to assist the NIAID and the nation by conducting basic and applied research designed to improve the prevention, diagnosis and treatment of naturally emerging and purposefully disseminated infectious diseases.. Larry Corey, MD. Principal Investigator, NIAID supported HIV Vaccine Trials Network (HVTN). Past President and Director, Fred Hutchinson Cancer Research Center . Professor. , Laboratory Medicine and . Paris 24 February 2015Preliminary results of the JIKI clinical trial to test the efficacy of favipiravir in reducing mortality in individuals infected by Ebola virus in Guinea Preliminary data from th TO IMPROVE VACCINE ACCEPTANCECommunications Cheat SheetThebenex00660069tsofGettingthevaccineAreturntoDamagefromAtransparentPharmaceuticalAmericasleadingSkeptical/concernedTheconsequencesGettingthevacc spread through direct contact (through broken skin or mucous membranes) with infected blood and body fluids . not spread through the air or by water. Individuals are only infectious when they have symptoms, which can appear up to 21 days after exposure. Outline. Review of a phase I trial. What is a phase II trial?. Phase II trial process. Standard trial designs. Innovative trial designs. Phase II trial examples. Guess that trial. Phase II thalidomide study. And Influenza Preparedness. Jimmy Guidry, MD - DHH. January 20, 2015. Agenda Topics. Ebola Status Update: What has changed in West Africa that impacts EVD planning for US?. First Responder Update. Flu Season Update. Fernandez-Garcia M, Majumdar M, Kebe O, Fall AD, Kone M, Kande M, et al. Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015. Emerg Infect Dis. 2018;24(1):65-74. https://doi.org/10.3201/eid2401.171174. Science . and . Politics. : . The . Case of The Ebola Clinical Trials . in . Ghana. Ama. . Edwin.  . MB.  ChB; MPhil (Psych); . D.Bioethics. Overview. . Ghana’s Role in the Ebola . Vaccine Clinical .